Introduction to Buprenorphine Prescribing in Primary Care

Introduction to Buprenorphine Prescribing in Primary Care is developed to support providers who are interested in prescribing buprenorphine.  This training is appropriate for providers who have taken the buprenorphine waiver training prior to 2022 or who have not yet begun treating patients for opioid use disorder.

This training meets the one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders. Please refer the following document for more information.

Providers who complete this training are eligible to complete an individual on-site observation with an experienced faculty preceptor. In-person observation sessions must be scheduled a minimum of four weeks in advance by contacting Caroline Drob, Program Assistant. Sessions are available on a first come, first serve basis.

On-site observation is limited to providers who practice within Philadelphia County. 

Space is limited.

Registration: https://www.eventbrite.com/e/483888211667

Cost: None

Credit: CME

CME Program Code: 23257

Target Audience:  Physicians, Physician Assistants, and Certified Registered Nurse Practitioners who have obtained their Buprenorphine Waiver training.

Learning Objectives:  After attending this program, participants will be able to:

1. Describe considerations for treating patients who have opioid use disorder that are unique to primary care
2. Describe practical and clinical considerations for providing LAI buprenorphine to patients
3. Define concepts of harm reduction and trauma informed care.
4. Review Philadelphia specific epidemiology and the rationale for treating patients for opioid use disorder in primary care.